Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment
Open Access
- 25 February 2021
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 29 (10) , 5691-5699
Abstract
Purpose: Taste and smell alterations (TAs and SAs) are often reported by patients with cancer receiving systemic antitumor therapy and can negatively impact food intake and quality of life. This study aimed to examine the occurrence of TAs and SAs and investigate the impact of TAs on overall liking of oral nutritional supplements (ONS) with warming and cooling sensations. Methods: Patients receiving systemic antitumor therapy completed a questionnaire on sensory alterations and evaluated overall liking of 5 prototype flavors of Nutridrink® Compact Protein (hot tropical ginger (HTG), hot mango (HM), cool red fruits (CRF), cool lemon (CL), and neutral (N)) on a 10-point scale via a sip test. Differences between patients with and without TAs were investigated using permutation analysis. Results: Fifty patients with various cancer types and treatments were included. Thirty patients (60%) reported TAs and 13 (26%) experienced SAs. Three flavors were rated highly with a liking score > 6 (CRF 6.8 ± 1.7; N 6.5 ± 1.9; HTG 6.0 ± 2.0). Larger variation in ONS liking scores was observed in patients with TAs with or without SAs (4.5–6.9 and 4.6–7.2, respectively) vs. patients without TAs (5.9–6.5). TAs were associated with increased liking of CRF (Δ = + 0.9) and N (Δ = + 1.0) flavors. Conclusions: TAs and SAs are common in patients with cancer undergoing systemic antitumor therapy. Patients with TAs were more discriminant in liking of ONS flavors compared to patients without TAs, and sensory-adapted flavors appeared to be appreciated. The presence of TAs should be considered when developing or selecting ONS for patients with cancer. Trial registration: Registration at ClinicalTrials.gov (NCT03525236) on 26 April 2018.Keywords
This publication has 35 references indexed in Scilit:
- Experiences and consequences of altered taste, flavour and food hedonics during chemotherapy treatmentSupportive Care in Cancer, 2012
- Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: Prevalence, course of severity, and quality of life correlatesActa Oncologica, 2011
- The changed meaning of food: Physical, social and emotional loss for patients having received radiation treatment for head and neck cancerEuropean Journal of Oncology Nursing, 2011
- Characterization of Chemosensory Alterations in Advanced Cancer Reveals Specific Chemosensory Phenotypes Impacting Dietary Intake and Quality of LifeJournal of Pain and Symptom Management, 2011
- Chemosensory Properties of the Trigeminal SystemACS Chemical Neuroscience, 2010
- Oral Nutritional Supplements Containing (n-3) Polyunsaturated Fatty Acids Affect the Nutritional Status of Patients with Stage III Non-Small Cell Lung Cancer during Multimodality TreatmentThe Journal of Nutrition, 2010
- A systematic review of dysgeusia induced by cancer therapiesSupportive Care in Cancer, 2010
- Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer CentresBritish Journal of Cancer, 2010
- The palatability of milk-based and non-milk-based nutritional supplements in gastrointestinal cancer and the effect of chemotherapyClinical Nutrition, 2005
- Aspects of taste and compliance in patients with cancerEuropean Journal of Oncology Nursing, 2005